Compounds > prazosin
Page last updated: 2024-11-03

prazosin and Di Guglielmo Disease

prazosin has been researched along with Di Guglielmo Disease in 2 studies

Prazosin: A selective adrenergic alpha-1 antagonist used in the treatment of HEART FAILURE; HYPERTENSION; PHEOCHROMOCYTOMA; RAYNAUD DISEASE; PROSTATIC HYPERTROPHY; and URINARY RETENTION.
prazosin : A member of the class of piperazines that is piperazine substituted by a furan-2-ylcarbonyl group and a 4-amino-6,7-dimethoxyquinazolin-2-yl group at positions 1 and 4 respectively.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fuchs, R2
Stelzer, I2
Haas, HS2
Leitinger, G2
Schauenstein, K2
Sadjak, A2
Schraml, E1
Allard, N1

Other Studies

2 other studies available for prazosin and Di Guglielmo Disease

ArticleYear
The alpha1-adrenergic receptor antagonists, benoxathian and prazosin, induce apoptosis and a switch towards megakaryocytic differentiation in human erythroleukemia cells.
    Annals of hematology, 2009, Volume: 88, Issue:10

    Topics: Adrenergic alpha-Antagonists; Apoptosis; Cell Differentiation; Cell Line, Tumor; Erythroid Cells; Hu

2009
α1-Adrenergic drugs modulate differentiation and cell death of human erythroleukemia cells through non adrenergic mechanism.
    Experimental cell research, 2011, Oct-01, Volume: 317, Issue:16

    Topics: Adrenergic alpha-1 Receptor Agonists; Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Apopt

2011